1. Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome 
Sung-Soo Park, Young-Woo Jeon, Gi June Min, Silvia Park, Seung-Ah Yahng, Jae-Ho Yoon, Seung-Hwan Shin, Sung-Eun Lee, Byung- Sik Cho, Ki-Seong Eom, Seok Lee, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Yoo-Jin Kim 
Biology of Blood and Marrow Transplantation 
Volume 25, Issue 1, Pages (January 2019)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Biology of Blood and Marrow Transplantation 2019 25, 63-72DOI: (10
Biology of Blood and Marrow Transplantation  , 63-72DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 1
(A) Estimated GRFS in total patients. (B) Distribution of GRFS events at 1 and 3 years. R indicates relapse; D, death from any cause; A, grades III to IV acute GVHD; C, chronic GVHD requiring systemic treatment.
Biology of Blood and Marrow Transplantation  , 63-72DOI: ( /j.bbmt )
Copyright © Terms and Conditions

4. Figure 2
(A) GRFS according to a scoring system constructed by using all factors affecting GRFS. (B) Distribution of GRFS events according to the scoring system.
Biology of Blood and Marrow Transplantation  , 63-72DOI: ( /j.bbmt )
Copyright © Terms and Conditions

5. Figure 3
Fixed factor–adjusted GRFS according to the combination of conditioning intensity and ATG dose.
Biology of Blood and Marrow Transplantation  , 63-72DOI: ( /j.bbmt )
Copyright © Terms and Conditions

6. Figure 4
(A) GRFS according to risk group of the f-GRFS model. (B) Distribution of GRFS events according to the scoring system for risk group of the f-GRFS model. (C) Discriminative GRFS by combination of RIC plus ATG ≥ 7.5 mg/kg in the low-risk group of the f-GRFS model. (D) Similar GRFS regardless of combination of RIC plus ATG ≥ 7.5 mg/kg in the high-risk group of the f-GRFS model.
Biology of Blood and Marrow Transplantation  , 63-72DOI: ( /j.bbmt )
Copyright © Terms and Conditions